Globus Medical, Inc. (GMED)

Globus Medical Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Net Income	537.87	102.98	122.87	190.17	149.19
Depreciation & Amortization	276.84	253.39	145.53	68.25	69.87
Loss (Gain) From Sale of Assets	12.53	5.55	1.54	0.3	0.46
Asset Writedown & Restructuring Costs	-	12.61	-	0.15	34.31
Loss (Gain) From Sale of Investments	-	-	-	5.39	2.78
Stock-Based Compensation	49.78	54.19	52.74	32.81	30.59
Provision & Write-off of Bad Debts	10.22	16.99	3.66	-0	1.2
Other Operating Activities	-67	172.48	33.76	-13.34	5.13
Change in Accounts Receivable	-52.18	-78.06	-49.91	-50.84	-25.9
Change in Inventory	-17.6	-29.86	-70.33	-61.75	-11.97
Change in Accounts Payable	8.49	17.66	-14.22	14.42	3.68
Change in Income Taxes	-50.85	-13.38	-0.41	-2.89	5.21
Change in Other Net Operating Assets	45.35	6.08	18.28	-4.21	11.72
Operating Cash Flow	753.45	520.64	243.5	178.47	276.27
Operating Cash Flow Growth	44.72%	113.81%	36.44%	-35.40%	38.98%
Capital Expenditures	-164.68	-115.43	-78.27	-74.05	-56.9
Cash Acquisitions	-252.55	-17.64	-296.03	-31.44	-34.49
Sale (Purchase) of Intangibles	-9.75	-	-	-	-
Investment in Securities	71.96	-42.99	677.27	-4.88	-284.55
Investing Cash Flow	-355.01	-176.05	302.97	-110.36	-375.94
Long-Term Debt Repaid	-449.99	-	-	-	-
Net Debt Issued (Repaid)	-449.99	-	-	-	-
Issuance of Common Stock	89.76	110.44	12.4	41.72	63.5
Repurchase of Common Stock	-303.36	-92.52	-236.18	-144.49	-
Other Financing Activities	-15.57	-45.62	-8.04	-7.19	-9.35
Financing Cash Flow	-679.16	-27.7	-231.82	-109.96	54.15
Foreign Exchange Rate Adjustments	22.45	0.26	2.18	-0.75	-0.81
Net Cash Flow	-258.28	317.15	316.83	-42.6	-46.33
Free Cash Flow	588.77	405.21	165.23	104.42	219.38
Free Cash Flow Growth	45.30%	145.25%	58.23%	-52.40%	62.34%
Free Cash Flow Margin	20.03%	16.08%	10.53%	10.21%	22.90%
Free Cash Flow Per Share	4.30	2.94	1.44	1.02	2.12
Cash Income Tax Paid	98.92	158.51	100.59	77.82	45.03
Levered Free Cash Flow	327.53	597.73	-346.13	75.52	160.53
Unlevered Free Cash Flow	327.53	600.35	-346.13	75.52	160.53
Change in Working Capital	-66.8	-97.55	-116.6	-105.26	-17.25

Updated Feb 24, 2026. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q